摘要
Background: Hepatocellular carcinoma (HCC) is the most common histological type of liver cancer, with an unsatisfactory long-term survival rate. Despite immune checkpoint inhibitors for HCC have got glories in recent clinical trials, the relatively low response rate is still a thorny problem. Therefore, there is an urgent need to screen biomarkers of HCC to predict the prognosis and efficacy of immunotherapy. @@@ Methods: Gene expression profiles of HCC were retrieved from TCGA, GEO, and ICGC databases while the immune-related genes (IRGs) were retrieved from the ImmPort database. CIBERSORT and WGCNA algorithms were combined to identify the gene module most related to CD8(+) T cells in the GEO cohort. Subsequently, the genes in hub modules were subjected to univariate, LASSO, and multivariate Cox regression analyses in the TCGA cohort to develop a risk signature. Afterward, the accuracy of the risk signature was validated by the ICGC cohort, and its relationships with CD8(+) T cell infiltration and PDL1 expression were explored. @@@ Results: Nine IRGs were finally incorporated into a risk signature. Patients in the high-risk group had a poorer prognosis than those in the low-risk group. Confirmed by TCGA and ICGC cohorts, the risk signature possessed a relatively high accuracy. Additionally, the risk signature was demonstrated as an independent prognostic factor and closely related to the CD8(+) T cell infiltration and PDL1 expression. @@@ Conclusion: A risk signature was constructed to predict the prognosis of HCC patients and detect patients who may have a higher positive response rate to immune checkpoint inhibitors.
学科与关键词
- Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma.Li, Yue; He, Xiaoqin; Zhang, Xiaoyu; Xu, Yangtao; Wu, Yaogui*; Xu, Ximing*Life Sciences, 2021, 265: 118799.
- Inflammatory Response-Related Long Non-Coding RNA Signature Predicts the Prognosis of Hepatocellular CarcinomaLi, Xinyu; Zhang, Shuqiao; Zhang, Shijun; Kuang, Weihong; Tang, Chunzhi*Journal of Oncology, 2022, 2022: 9917244.被引 5
- A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular CarcinomaLiu, Jun; Lu, Jianjun; Li, Wenli*2021, 2021: 5546032.被引 8
